111 filings
Page 2 of 6
8-K
c3x1c6hjjqb6om fj
9 Jun 23
Regulation FD Disclosure
12:15pm
8-K
bhfil 4eprqxj3ach58
2 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
ixc02kid4mi6bmij4gda
24 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:53pm
8-K
4zkj 2dhc
12 May 23
Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
892zopzkc2 wugolmmq
10 May 23
Adial Pharmaceuticals Receives Notice of Exercise from
4:15pm
8-K
s3ho06
13 Apr 23
Submission of Matters to a Vote of Security Holders
4:19pm
8-K
x2s h0mczrwp3p1ucub
31 Mar 23
Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update
6:07am
8-K
bj5xddph 0960z8
21 Mar 23
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
9:15am
8-K
8ji3 lknj6gjt
7 Mar 23
Adial Pharmaceuticals Provides Update on Regulatory Strategy for AD04 for Treatment of Alcohol Use Disorder
4:05pm
8-K
lbh7gtda0 lmaci6j
2 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:27am
8-K
e1sfbef
27 Feb 23
Adial Pharmaceuticals Announces Closing of $0.75 Million At-The-Market Registered Direct Offering
9:27am
8-K
snyqwlhdchtt9xi7hv
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
fitpd8h2
21 Feb 23
Type C meeting with FDA set for Second Quarter
9:06am
8-K
gnm0kb
1 Feb 23
Adial Pharmaceuticals Enters Into Option Agreement
4:13pm
8-K
wzj4s
15 Nov 22
Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
7:00am
8-K
cgbxdey71sod6
13 Oct 22
Departure of Directors or Certain Officers
4:56pm
8-K
2gbhoo0jn38frj
26 Sep 22
Adial Pharmaceuticals Announces Positive In Vivo Data for Purnovate’s PNV-5030 as a Potential Treatment for Chronic Pain
5:00pm
8-K
pw0481r22vuecbdsl pe
14 Sep 22
Changes in Registrant's Certifying Accountant
4:56pm
8-K
5n2a7byx7o0 0jou3zk
13 Sep 22
Departure of Directors or Certain Officers
6:02am
8-K
i4plw
6 Sep 22
Adial Pharmaceuticals Announces Positive In-Vivo Non-clinical Data with Purnovate’s
9:10am